Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE

A. Dilektasli (Bursa, Turkey)

Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Session: COPD: from screening to risk factors of lung cancer
Session type: Thematic Poster
Number: 1208
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Dilektasli (Bursa, Turkey). Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE. 1208

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk Score for Subclinical COPD: The NHLBI Pooled Cohorts Study
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


Detecting uncontrolled asthma in children: (Childhood) Asthma Control Test versus GINA-guidelines and Asthma Control Questionnaire
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010


Validation of the Clinical COPD Questionnaire (CCQ) in Swedish primary care
Source: Eur Respir J 2005; 26: Suppl. 49, 671s
Year: 2005

Diagnostic sensitivity of a symptom-based questionnaire, the Canadian Lung Health Test (CLHT), in subjects at risk for COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005

Agreement Between COPD Assessment Test (CAT) And Modified Medical Research Council (mMRC) Dyspnea Scores For GOLD COPD Classification: A Cross-Sectional Analyses
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019

A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG)  in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Impact of frailty on interpretability of spirometry: The Rotterdam study
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

Title Development and preliminary psychometric testing of the Respiratory Nurse Sensitive Outcome Indicator tool (RNSOI) for patients with COPD.
Source: International Congress 2017 – Delivering person-centred care across the spectrum of respiratory nursing
Year: 2017



(in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study)
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Characterising the Adult Obese-Difficult Asthma Phenotype within the WATCH cohort
Source: International Congress 2018 – Asthma analysis
Year: 2018



Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): a modified Delphi exercise to identify a core dataset for asthma and COPD studies
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020


COPD - Impact on Mortality in Locals with and without Specific Medication
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Assessing an Educational Intervention to Improve Recognition of Frailty in Hospitalized Patients with COPD
Source: International Congress 2019 – Medical education
Year: 2019

Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


FASE-CPHG Study: Identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group
Source: International Congress 2017 – Notable abstracts in asthma
Year: 2017



LATE-BREAKING ABSTRACT: Identity Consequence Fatigue Scale (ICFS) in COPD: Correlation with Severity, Risk of Hospitalization and Length of stay
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Evaluation Of 24-Hour Day Respiratory Symptoms And GOLD Classification System In COPD Patients From Seven Latin America Countries: The LASSYC Study
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019